Therefore, based on the numerous findings that show the inflammasome to be associated with a neuroinflammatory response and the pathogenesis of AD, attention has been focused on the NLRP3 inflammasome as a possible therapeutic target for treatment of AD. The gene discussed is NLRP3; the disease is Alzheimer disease.